I agree that this site is using cookies. You can find further informations here.
X
Meads, Mark
125  results:
Search for persons X
?
1

#1. Acid ceramidase (ASAH1) is a key mediator of drug resis..:

Bishop, Ryan T. ; Li, Tao ; Alugubelli, Raghunandan R....
Journal of Bone Oncology.  45 (2024)  - p. 100539 , 2024
Link: https://doi.org/10.1016/..
 
?
2

P-361 Genomic and transcriptomic landscape of hyper-APOBEC ..:

Papadimitriou, Marios ; Ziccheddu, Bachisio ; Youssfi, Abdessamad...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S238 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P-217 ULK3-mediated autophagy is a tractable therapeutic ta..:

Tauro, Marilena ; Li, Tao ; Meads, Mark...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S155 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P-115: Unc-51 Like Kinase 3 protein (ULK3)-mediated autopha..:

Tauro, Marilena ; Li, Tao ; Meads, Mark...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S98-S99 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Treatment of acquired drug resistance in multiple myeloma b..:

Turner, Joel G. ; Dawson, Jana L. ; Grant, Steven...
Journal of Hematology & Oncology.  9 (2016)  1 - p. , 2016
Link: https://doi.org/10.1186/..
 
?
6

XPO1 inhibitor combination therapy with bortezomib or carfi..:

Turner, Joel G. ; Kashyap, Trinayan ; Dawson, Jana L....
Oncotarget.  7 (2016)  48 - p. 78896-78909 , 2016
Link: https://doi.org/10.18632..
 
?
7

An Organotypic High Throughput System for Characterization .. 

JoVE : Medicine
Silva, Ariosto ; Jacobson, Timothy ; Meads, Mark.. , 2015
Link: https://www.jove.com/t/5..
 
?
8

Bortezomib restores stroma‐mediated APO2L/TRAIL apoptosis r..:

Perez, Lia E. ; Parquet, Nancy ; Meads, Mark..
European Journal of Haematology.  84 (2010)  3 - p. 212-222 , 2010
Link: https://doi.org/10.1111/..
 
?
9

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism a..:

Burger, Karen L. ; Fernandez, Mario R. ; Meads, Mark B....
Cancer Research.  83 (2023)  23 - p. 3901-3919 , 2023
Link: https://doi.org/10.1158/..
 
?
10

Plasma cell dependence on histone/protein deacetylase 11 re..:

Mostofa, AGM ; Distler, Allison ; Meads, Mark B....
JCI Insight.  6 (2021)  24 - p. , 2021
Link: https://doi.org/10.1172/..
 
?
11

IAP and HDAC inhibitors interact synergistically in myeloma..:

Zhou, Liang ; Zhang, Yu ; Meads, Mark B....
Blood Advances.  5 (2021)  19 - p. 3776-3788 , 2021
Link: https://doi.org/10.1182/..
 
?
12

Transcriptional programming drives Ibrutinib-resistance evo..:

Zhao, Xiaohong ; Wang, Michelle Y. ; Jiang, Huijuan...
Cell Reports.  34 (2021)  11 - p. 108870 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Metabolic Changes Are Associated with Melphalan Resistance ..:

Koomen, David C. ; Meads, Mark B. ; Magaletti, Dario M....
Journal of Proteome Research.  20 (2021)  6 - p. 3134-3149 , 2021
Link: https://doi.org/10.1021/..
 
?
14

Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 ..:

Hasipek, Metis ; Grabowski, Dale ; Guan, Yihong...
Cancers.  13 (2021)  11 - p. 2649 , 2021
Link: https://doi.org/10.3390/..
 
?
15

A pharmacodynamic model of clinical synergy in multiple mye..:

Sudalagunta, Praneeth ; Silva, Maria C. ; Canevarolo, Rafael R....
EBioMedicine.  54 (2020)  - p. 102716 , 2020
Link: https://doi.org/10.1016/..
 
1-15